MPTI V1
Research type
Research Study
Full title
A novel assessment to detect the adequacy of past psychological treatments for depression: The Maudsley Psychological Treatment Inventory (MPTI)
IRAS ID
309985
Contact name
Anthony Cleare
Contact email
Sponsor organisation
King's College London
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Depression is a common and disabling illness that requires effective treatment to reduce symptoms and improve quality of life. Clinical guidelines recommend psychological therapies and antidepressant medication for the treatment of depression. However, around half of people with depression do not benefit from these treatments. Common factors that have been identified as important in determining whether people benefit from psychological therapy include the relationship between the patient and therapist, therapist skill, frequency and intensity of therapy sessions, and whether the patient practises their skills and completes homework outside of therapy.
Based on this research, we have developed a tool to measure important aspects of psychological therapies, to give an overall rating of adequacy of therapy in relation to clinical guidelines, the Maudsley Psychological Treatment Inventory (MPTI). The MPTI contains different modules for seven different psychological therapies recommended for the depression: Cognitive Behavioural Therapy (CBT), Interpersonal Psychotherapy, Behavioural Activation, Psychodynamic psychotherapy, computerised CBT, guided self-help, and mindfulness-based CBT. The objective of the study is to understand whether this new tool accurately measures treatment adequacy, and whether it can predict response to treatment in adults with a history of depression.
Adults with depression who engaged in a course of psychological therapy in South London and Maudsley NHS trust within the past two years will be eligible to take part. Participation will involve a 15 minute phone or video call with a researcher. During the call, the researcher will explain the study and send a link to the participant to complete the consent form if they wish to take part. They will also ask some questions to ensure the participant is eligible to take part, and then administer the MPTI. The researcher will also obtain clinical information from the participants notes regarding the therapy they received.REC name
London - Riverside Research Ethics Committee
REC reference
22/LO/0254
Date of REC Opinion
12 May 2022
REC opinion
Further Information Favourable Opinion